🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This week on MENT TO BE, we are joined by Lauren Phillips, CPO of BioBox Analytics In this clip, Lauren talks about the mission of BioBox and how they are shaping the techbio field. Stream the full episode here: ment-to-be.simplecast.com New episode every Tuesday! #mentorship

This week on MENT TO BE, we are joined by Lauren Phillips, CPO of BioBox Analytics In this clip, Lauren gives advice to women interested in tech startups. Stream the full podcast episode here: ment-to-be.simplecast.com New episode every Tuesday! #mentorship #careers

Julian Mazzitelli | BioBox giving his talk on GitOps at the Q2 Toronto CNCF Meetup

“Nobody likes purple ketchup” - well said Julian Mazzitelli | BioBox

🚀Exciting news to share! Our latest update unleashes the BioBox Knowledge Engine. Built upon 80k+ datasets and 4.6 billion observations, the engine is the most powerful way for scientists to identify and validate targets faster. Contact us to learn more!

Having data is not the same as having knowledge. Big pharma teams are using Knowledge Graphs to accelerate drug discovery and get assets to market faster. Here's how they do it: blog.biobox.io/p/beyond-data-…

Beyond Data: The Rise of Knowledge Graphs in Accelerating Drug Discovery fantastic log post by ⁦BioBox Analytics⁩ blog.biobox.io/p/beyond-data-…

Thrilled to collaborate with leading AI researchers at Vector Institute through this partnership! linkedin.com/posts/toronto-…

🚀Excited to share our latest update to the BioBox Analytics platform. Introducing the Graph Explorer - a seamless way to build a GPS for disease biology in drug discovery. Interactively explore a canvas of highly connected multi-modal biological data, all in one place. To

🚀We've just shipped a major update! To learn more about the BioBox Graph Explorer - check out our blog post here: blog.biobox.io/p/building-a-g…

Platform therapeutic companies that can zero-in on high quality causal drug targets will win in the next decade. Lauren Phillips(Lauren Phillips) discusses the impact in our latest blog post 👇 Bottom line is that drug discovery is a business activity, which disincentivizes

Check out our latest blog post by Lauren Phillips (Lauren Phillips) breaking down what the new FDA guidelines could mean for platform therapeutic companies 👇 blog.biobox.io/p/from-technol…

🚀 BioBox v5.3.0 just landed! Data packages now have their data dependencies mapped, ensuring your graph is semantically sound. Exporting network graphs as .png and extracting nodes and edges into a .csv file Read the release notes here: docs.biobox.io/release-notes/…

🚀 v5.5.0 is out with some highly requested updates! Object Views and Search. Find any object in your data graph quickly with smart lookups. Remove unused data packages from your graph. Read more about it here👇 docs.biobox.io/release-notes/…

Knowledge Infrastructure for the Modern Biopharma. Check out our latest post where we highlight how teams are using the BioBox platform to solve complex drug discovery challenges. blog.biobox.io/p/knowledge-in…

"...the true value of a knowledge graph lies not in its complexity but in its utility." Check out our latest blog post by Christopher Li where we share guidance on how to do useful things with multi-omic knowledge graphs. #KnowledgeGraph #multiomics blog.biobox.io/p/how-to-trans…

Long non-coding RNAs will be the next gold mine for novel drug targets. In the past two weeks, we saw two major partnerships announced, specifically hunting for lncRNA targets: HAYA Therapeutics and Eli Lilly and Company - $1B+ NextRNA and Bayer AG - $550M+ The hardest part is deciding

Pioneering startup in drug discovery knowledge management, BioBox Analytics has won the inaugural Innovation Incubator competition at the AI Driven Drug Discovery Summit in Boston: utest.to/2024/11/19/bio…… #AI #Drugdiscovery University of Toronto University of Toronto Entrepreneurship

Scientists in drug discovery work with a lot of data. They're expected to translate this complexity into clear high-impact decisions that can shape entire drug programs. BioBox simplifies this with our Graph Reasoning Models! Learn more here 👇

Today, I’m thrilled to share the public launch of AXL, a new venture studio building the next generation of AI-powered companies, right here in Canada.